ResMed develops cloud-connected medical devices and digital health technologies designed to treat chronic respiratory and sleep conditions while enabling care outside hospital settings. Founded in Australia in 1989, the company operates across three main segments: sleep apnea management, respiratory care for conditions such as COPD, and out-of-hospital care software platforms. Its product portfolio includes CPAP machines, bilevel devices, ventilators, masks, accessories, and digital health solutions that work in concert to deliver care.
The company operates at substantial scale, with over 10,000 employees serving patients across more than 140 countries. In the past 12 months, ResMed's devices, masks, accessories, and digital solutions impacted 154 million lives. The organisation aims to extend this reach to 500 million lives by 2030. Its Residential Care Software segment supports healthcare professionals and caregivers managing patient care in homes and chosen care settings, reflecting a strategic focus on shifting treatment away from institutional environments.
ResMed's technical work spans digital health platforms, medical device engineering, cloud connectivity, and care management software. The company positions itself as serving the growing demand for chronic disease management solutions in an ageing population, with particular emphasis on enabling healthcare delivery outside traditional hospital infrastructure.
